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M em b ers  of th e  c y s te in e -r ic h  p ro te in  (CRP) fam ily  a re  
e v o lu tio n a rily  c o n se rv e d  p ro te in s  th a t  h a v e  b e e n  im p li­
c a te d  in  th e  p ro c e sse s  of ce ll p ro life ra tio n  a n d  d if fe re n ­
t ia tio n . In  p a r t ic u la r ,  on e  C R P  fam ily  m e m b e r  h a s  b e e n  
sh o w n  to  b e  a n  e s s e n tia l r e g u la to r  o f c a rd ia c  a n d  sk e l­
e ta l  m u sc le  d ev e lo p m e n t. E a c h  o f th e  th r e e  v e r te b ra te  
C R P  iso fo rm s c h a ra c te r iz e d  to  d a te  is  com p o sed  of tw o  
co p ies  of th e  z in c -b in d in g  LIM  d o m a in  w ith  a s so c ia te d  
g ly c in e -r ich  re p e a ts .  In  th is  s tu d y , w e h a v e  a d d re s se d  
th e  b io lo g ica l s ig n ific an c e  of th e  C R P  m u ltig e n e  fam ily  
b y  c o m p a r in g  th e  s u b c e llu la r  d is tr ib u t io n s , b io c h e m ic a l 
p ro p e r tie s ,  a n d  e x p re ss io n  p a t te r n s  of CR P1, CR P2, a n d  
C R P3/M LP. O u r  d a ta  re v e a l th a t  a ll th r e e  C R P  fam ily  
m em b ers , w h e n  e x p re sse d  in  a d h e re n t  f ib ro b la s ts , a s so ­
c ia te  sp ec ifica lly  w ith  th e  a c tin  cy to sk e le to n . M oreover, 
a ll th r e e  C R P  iso fo rm s a re  c a p a b le  of in te r a c t in g  w ith  
th e  c y to sk e le ta l p ro te in s  a -a c tin in  a n d  zyxin . T o g e th er , 
th e s e  o b se rv a tio n s  su g g e s t th a t  C R P  fam ily  m e m b ers  
m ay  e x h ib it  o v e r la p p in g  c e llu la r  fu n c tio n s . D iffe re n ce s  
b e tw e e n  th e  th r e e  C R P s a re  e v id e n t in  th e i r  p ro te in  
e x p re ss io n  p a t te r n s  in  c h ic k  em b ry o s. C R P1 e x p re ss io n  
is  d e te c te d  in  a  v a r ie ty  of o rg a n s  e n r ic h e d  in  sm o o th  
m u sc le . C R P2 is  r e s t r ic te d  to  a r te r ie s  a n d  f ib ro b la s ts . 
C R P3/M LP is  d o m in a n t in  o rg a n s  e n r ic h e d  in  s t r ia te d  
m u sc le . C R P  iso fo rm  e x p re ss io n  is  a lso  d ev e lo p m e n ta lly  
r e g u la te d  in  th e  ch ick . O u r  f in d in g s  su g g e st th a t  th e  
th r e e  C R P  fam ily  m e m b ers  p e r fo rm  s im ila r  fu n c tio n s  in  
d if fe re n t m u sc le  d e r iv a tiv e s . T h e  d e m o n s tra t io n  th a t  a ll 
m e m b e rs  o f th e  C R P  fam ily  a re  a s so c ia te d  w ith  cy- 
to s k e le ta l c o m p o n en ts  th a t  h a v e  b e e n  im p lic a te d  in  th e  
assem b ly  a n d  o rg a n iz a tio n  of f ila m e n to u s  a c t in  su g g e s ts  
th a t  C R P s c o n tr ib u te  to  m u sc le  ce ll d if fe re n tia t io n  v ia  
effec ts  on  c y to a rc h ite c tu re .
Members of the cysteine-rich protein (CRP)1 family are evo­
lutionarily conserved proteins that have been implicated in 
myogenesis. CRPs exhibit a common domain structure, being 
composed primarily of two tandemly arrayed LiM domains (1,
* T h i s  w o r k  w a s  s u p p o r t e d  i n  p a r t  b y  g r a n t s  f r o m  t h e  N a t i o n a l  
I n s t i t u t e s  o f  H e a l t h  a n d  t h e  A m e r i c a n  C a n c e r  S o c ie ty , N a t i o n a l  R e ­
s e a r c h  S e rv ic e  A w a r d  P r e d o c t o r a l  F e l lo w s h ip  5 F 3 1 G M 1 4 8 3 2 - 0 5  (to  
J .  D . P .) ,  N a t i o n a l  I n s t i t u t e s  o f  H e a l t h  P r e d o c t o r a l  T r a i n i n g  G r a n t  
C A 0 9 6 0 2  ( to  K . L . S .) , a n d  a  P h i l i p p e  F o u n d a t i o n  g r a n t  ( to  P . P .) . T h e  
w o r k  p e r f o r m e d  in  t h e  u n i v e r s i t y  o f  u t a h  o l i g o n u c le o t id e  S y n th e s i s  
F a c i l i t y  w a s  s u p p o r t e d  b y  N a t i o n a l  I n s t i t u t e s  o f  H e a l t h  G r a n t  
C A 4 2 0 1 4 .
t  R e c ip ie n t  o f  a  f a c u l ty  r e s e a r c h  a w a r d  f r o m  t h e  A m e r i c a n  C a n c e r  
S o c ie ty . T o  w h o m  c o r r e s p o n d e n c e  s h o u ld  b e  a d d r e s s e d :  D e p t .  o f  B io lo g y , 
2 0 1  S o u th  B io lo g y  B ld g ., U n iv e r s i t y  o f  U t a h ,  S a l t  L a k e  C ity ,  U T  8 4 1 1 2 ­
0 8 4 0 . T e l.: 8 0 1 -5 8 1 -4 4 8 5 ;  F a x :  8 0 1 -5 8 1 -4 6 6 8 ;  E -m a il :  b e c k e r le @  
b io s c i e n c e .u t a h .e d u .
1 T h e  a b b r e v i a t i o n s  u s e d  a r e :  C R P , c y s te in e - r ic h  p r o te in ;  P A G E , p o ly ­
a c r y l a m i d e  g e l  e le c t r o p h o r e s i s .
2). Each LIM domain, defined by the consensus sequence 
CX2CX16-23HX2CX2CX2CX16-2:lCX2-3(C/H/D), displays two 
closely associated zinc-binding modules or “fingers” (3-7). A 
number of recent investigations have indicated that LIM do­
mains are capable of functioning as specific protein-binding 
interfaces and are found in a variety of proteins that are in­
volved in cell differentiation (reviewed in Refs. 8  -11). A typical 
LIM protein displays multiple copies of the LIM motif. By 
virtue of their protein binding capabilities, the LIM regions of 
proteins are thought to be important for targeting proteins to 
specific subcellular locations and for mediating the assembly of 
multimeric protein complexes (9, 12, 13). Because of the pres­
ence of two LIM domains in their structures, CRP family mem­
bers have been proposed to serve as scaffolds that link protein 
partners in a productive fashion (9, 14).
Three members of the CRP family (CRP1, CRP2, and CRP3/ 
MLP) have been characterized in vertebrates (1, 15-20). The 
first CRP family member to be identified was CRP1 (15, 16). 
CRP1 sequences are conserved within vertebrates, being 92% 
identical at the amino acid level in chick and human (15, 16, 
18). In fibroblasts, CRP1 is localized at adhesion plaques and in 
association with filamentous actin (16, 18, 21). CRP1 has been 
purified to homogeneity from chicken gizzard, and much is 
known about its biochemical properties (18). Two protein-bind­
ing partners have been identified for CRP1; CRP1 interacts 
directly with the adhesion plaque protein, zyxin (9, 16, 22), and 
with the actin-cross-linking protein, a-actinin (21). Both zyxin 
and a-actinin are important regulators of actin cytoskeletal 
organization (23-25).
The transcript encoding CRP2 was identified in a subtractive 
hybridization screen for genes whose expression is significantly 
reduced in myc-transformed cells (1, 17). Subsequent studies 
revealed that CRP2 mRNA is undetectable in a variety of 
oncogenically and chemically transformed cells and that the 
dramatic loss of CRP2 expression correlates with the acquisi­
tion of the transformed phenotype (1, 17). As has been shown 
for CRP2, CRP1 expression is also reduced significantly upon 
fibroblast cell transformation (1). Thus, expression of both 
CRP1 and CRP2 is inversely correlated with cell proliferation.
The third CRP family member, referred to as MLP (muscle 
LIM protein) or CRP3, was originally identified in a subtractive 
hybridization screen designed to find genes whose expression 
was up-regulated in skeletal muscle after denervation (19). 
Products of genes that exhibit this property represent candi­
date myogenic factors. The possible involvement of CRP3/MLP 
in muscle differentiation was first tested using cultured C2 
myoblasts. Consistent with the findings showing that CRP1 
and CRP2 protein levels are highest in cells displaying a nor­
mal differentiated phenotype, CRP3/MLP expression was 
shown to be up-regulated dramatically when the C2 myoblasts 
were stimulated to exit the cell cycle and differentiate. Using
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the same culture system, it was demonstrated that elimination 
of CRP3/MLP by antisense oligonucleotide expression blocked 
muscle differentiation in these cells (19). Moreover, overexpres­
sion of CRP3/MLP in presumptive myoblasts enhanced the 
progression of the myogenic program (19). From the studies of 
myogenic cells in culture, it appeared that CRP3/MLP was 
essential for muscle differentiation. In fact, recent gene disrup­
tion studies in the mouse have confirmed the requirement for 
CRP3/MLP in both cardiac and skeletal muscle differentiation 
(26). The involvement of CRP3/MLP in the execution of the CD myogenic program comes late in the differentiation pathway,
after the time that cells are determined in response to factors 
including the basic helix-loop-helix proteins MyoD and myoge- 
nin. In mice that lack CRP3/MLP expression, the muscle cell 
cytoarchitecture is disturbed, and the normal semicrystalline 
arrays of contractile proteins fail to organize (26).
Based on the fact that another CRP family member, CRP1, 
has been shown to interact directly with the cytoskeletal pro­
teins zyxin and a-actinin, it was postulated that failure of 
CRP3/MLP homozygous m utant mice to assemble myofibrillar 
arrays is due to defects in processes that depend on interac­
tions between CRP3/MLP and cytoskeletal partners (21). How­
ever, direct support for this hypothesis was lacking since no 
protein-binding partners had been identified for CRP3/MLP. In 
this report, we compare the abilities of the three CRP family 
members to interact with zyxin and a-actinin and to associate 
with the actin cytoskeleton. By monitoring transient expres­
sion of epitope-tagged versions of each CRP isoform and by 
performing protein binding assays, we have demonstrated that 
the three family members display similar subcellular localiza­
tions and biochemical properties. Our inability to distinguish 
between the three CRP isoforms based on functional criteria 
led us to speculate that the different CRP family members 
might be expressed in distinct locations within the organism. 
We have generated isoform-specific antibodies directed against 
each of the chick CRPs and have demonstrated that these three 
gene products exhibit distinct patterns of expression with only 
limited overlap. Also, for those organs examined, each CRP 
family member displays a characteristic expression profile dur­
ing embryonic development. The results of our analysis are 
consistent with the idea that CRP family members have com­
parable functions that are executed in distinct locations within 
vertebrate organisms. Our findings make interesting predic­
tions about the mechanism of action of CRP3/MLP in cardiac 
and skeletal muscle cell differentiation and about the roles of 
CRP1 and CRP2 in other contractile cells.
E X P E R IM E N T A L  P R O C E D U R E S  
Heterologous Expression of CRP1, CRP'2, and CRP3IMLP in Cul­
tured REF52 Cells— M a m m a l i a n  e x p r e s s io n  v e c to r s  w e r e  e n g i n e e r e d  to  
e x p r e s s  M y c  e p i to p e - t a g g e d  c h i c k e n  C R P 1 , C R P 2 , o r  C R P 3 /M L P  in  
c u l t u r e d  f i b r o b l a s t s  u s i n g  m e th o d s  d e s c r i b e d  p r e v io u s ly  (2 , 2 1 , 27 ). C R P  
c o d in g  r e g io n s  w e r e  a m p l i f i e d  i n  p o ly m e r a s e  c h a in  r e a c t io n s  u s i n g  Pfu 
p o ly m e r a s e  ( S t r a t a g e n e ,  L a  J o l l a ,  C A ) a n d  C R P -s p e c if ic  p r im e r s  s u p ­
p l e m e n t e d  w i t h  EeoR V  a n d  Notl r e s t r i c t i o n  e n z y m e  r e c o g n i t i o n  s i t e s .  
O n c e  d ig e s t e d  w i t h  Eeo R V  a n d  Notl, t h e  a m p l i f i e d  f r a g m e n t s  w e r e  
l i g a t e d  in t o  t h e  p o ly l in k e r  o f  t h e  p c D N A l /N E O  v e c to r  ( I n v i t r o g e n ,  S a n  
D ie g o , C A ). T h e  p c D N A l /N E O  v e c to r  u s e d  i n  t h e s e  s tu d i e s  w a s  s u p p le ­
m e n t e d  w i t h  a  s e q u e n c e  e n c o d in g  a n  a n t ig e n i c  p e p t id e  f r o m  t h e  c -M y c  
p r o t e in  ( E Q K L IS E E D L L )  (2 1 ); t h i s  m o d i f ic a t io n  a l lo w e d  f o r  t h e  e x p r e s ­
s io n  o f  t h e  C R P s  w i t h  a  C - t e r m in a l  c -M y c  e p i to p e  t a g .  A ll  C R P  e x p r e s ­
s io n  v e c to r s  w e r e  s e q u e n c e d  p r io r  to  u s e  v ia  a u t o m a t e d  s e q u e n c in g  
te c h n o lo g y  o n  a  M o d e l 3 7 3 A  D N A  s e q u e n c e r  ( A p p lie d  B io s y s te m s ,  In c . ,  
F o s t e r  C i ty ,  C A ). L a r g e - s c a le  p u r i f i c a t i o n s  o f  p l a s m id  D N A s  w e r e  p e r ­
f o r m e d  u s i n g  a  p o ly e th y le n e  g ly c o l p r e c i p i t a t i o n  p r o c e d u r e  (2 8 ) . P u r i ­
f i e d  p la s m id s ,  r e s u s p e n d e d  a t  a  c o n c e n t r a t i o n  o f  2 5 0  n g //x l i n  p h o s ­
p h a t e - b u f f e r e d  s a l i n e ,  w e r e  m ic r o in j e c te d  in t o  R E F 5 2  c e l ls  t h a t  h a d  
b e e n  p l a t e d  o n to  g l a s s  c o v e rs l ip s .  A f t e r  a  2 4 -h  i n c u b a t i o n  a t  3 7  °C , c e lls  
w e r e  f ix e d  a n d  p r o c e s s e d  f o r  im m u n o f lu o r e s c e n c e  m ic ro s c o p y .







a  1 :3  m i x tu r e  o f  H a m ’s  F -1 2  m e d iu m  a n d  D u lb e c c o ’s  m o d i f ie d  E a g le ’s 
m e d iu m  c o n t a in i n g  1 0 %  f e t a l  b o v in e  s e r u m  (2 9 ) . F o r  im m u n o f lu o r e s ­
c e n c e  a n a ly s e s ,  c e l ls  w e r e  g r o w n  to  5 0 - 7 0 %  c o n f lu e n c e  o n  g l a s s  c o v e r ­
s l ip s .  I n d i r e c t  im m u n o f lu o r e s c e n c e  w a s  p e r f o r m e d  e x a c t ly  a s  d e s c r ib e d  
p r e v io u s ly  (3 0 ) . A  m o u s e  m o n o c lo n a l  a n t ib o d y  d i r e c t e d  a g a i n s t  th e  
c -M y c  p e p t id e  e p i to p e  ( A m e r i c a n  T y p e  C u l t u r e  C o lle c t io n ,  R o c k v ille , 
M D ) w a s  u s e d  a s  a  p r i m a r y  a n t ib o d y  to  d e t e c t  h e t e r o lo g o u s  e x p r e s s io n  
a n d  lo c a l i z a t i o n  o f  M y c - ta g g e d  v e r s io n s  o f  C R P 1 , C R P 2 , o r  C R P 3 /M L P  
i n  c u l tu r e d  c e lls .  P r i m a r y  a n t ib o d ie s  w e r e  d e t e c te d  u s in g  f lu o r e s c e in  
i s o th i o c y a n a te - c o n j u g a te d  g o a t  a n t i - m o u s e  s e c o n d a r y  a n t ib o d ie s  (C a p -  
p e l ,  D u r h a m ,  N C ) . F - a c t in  w a s  m o n i to r e d  b y  in c u b a t i n g  f ix e d  c e l ls  w i th  
r h o d a m in e - c o n j u g a t e d  p h a l lo id i n  ( M o le c u la r  P r o b e s ,  I n c . ,  E u g e n e ,  O R ).
Expression, Purification, and Quantitation of Recombinant CRPs—  
C h ic k e n  C R P 1  a n d  C R P 2  w e r e  p r o d u c e d  a s  r e c o m b in a n t  p r o t e in s  i n  
b a c t e r i a .  A s  d e s c r ib e d  p r e v io u s ly ,  C R P 1  c D N A  s e q u e n c e s  w e r e  s u b ­
c lo n e d  in t o  a  p E T 5  e x p r e s s io n  v e c to r  ( N o v a g e n , M a d is o n ,  W I)  s u c h  t h a t  
C R P 1  w a s  t r a n s l a t e d  f r o m  i t s  e n d o g e n o u s  s t a r t  c o d o n , w i t h o u t  a n y  
a d d i t i o n a l  l e a d e r  s e q u e n c e s  (4 ). S im i l a r  p ro to c o ls  w e r e  e m p lo y e d  to  
g e n e r a t e  a  p E T 5 - C R P 2  e x p r e s s io n  v e c to r .  C lo n e d  c D N A  s e q u e n c e s  w e r e  
v e r i f ie d  b y  d o u b le - s t r a n d e d  D N A  s e q u e n c e  a n a ly s i s  (cy c le  s e q u e n c in g  
k i t ,  L i fe  T e c h n o lo g ie s ,  In c .) .  B o th  C R P 1  a n d  C R P 2  w e r e  e x p r e s s e d  a n d  
p u r i f i e d  u s i n g  p r o to c o ls  d e s c r i b e d  p r e v io u s ly  f o r  C R P 1  (3 , 4). B r ie f ly , 
e x p r e s s io n  v e c to r s  w e r e  i n t r o d u c e d  in t o  B L 2 1 (D E 3 )  c e lls ,  a n d  t r a n s ­
f o r m e d  c e l ls  w e r e  g r o w n  i n  L B  m e d iu m  s u p p le m e n te d  w i t h  2 0 0  x g /m l  
a m p ic i l l i n  ( S ig m a )  to  A 600 =  0 .7 -  0 .9 . P r o t e i n  e x p r e s s io n  w a s  in d u c e d  
f o r  3  h  a t  3 7  °C  i n  t h e  p r e s e n c e  o f  0 .4  m M  is o p ro p y l- ^ -D - th io g a la c to p y -  
r a n o s id e  (S ig m a ) .  T o  p u r i f y  r e c o m b in a n t  C R P 1  a n d  C R P 2 , 1 l i t e r  o f  
in d u c e d  c e l ls  w a s  h a r v e s t e d  b y  c e n t r i f u g a t io n ,  r e s u s p e n d e d  i n  2 0  m l  o f  
ly s i s  b u f f e r  (1 0  m M  K C l, 10  m M  d i t h io th r e i t o l ,  a n d  10  m M  p o ta s s iu m  
p h o s p h a te  ( p H  7 .2 )) , a n d  h o m o g e n iz e d  b y  m a c r o t i p  s o n ic a t io n  ( B r a n s o n  
U l t r a s o n i c s  C o rp . ,  D a n b u r y ,  C T ). T h e  r e s u l t i n g  ly s a t e s  w e r e  f r a c t i o n ­
a t e d  b y  c e n t r i f u g a t io n ,  a n d  t h e  s u p e r n a t a n t  w a s  d ia ly z e d  o v e r n ig h t  
a g a i n s t  B u f f e r  C 2  (0 .0 1 %  2 - m e r c a p to e th a n o l  a n d  10  m M  p o ta s s iu m  
p h o s p h a te  (p H  7 .2 )) . T h e  d ia ly z e d  s a m p l e  w a s  lo a d e d  o n to  a  C M 5 2  
c a t io n - e x c h a n g e  c o lu m n  p r e - e q u i l i b r a t e d  i n  B u f f e r  C 2 . A f t e r  e x t e n s iv e  
w a s h in g  w i t h  B u f f e r  C 2 , p u r i f i e d  C R P 1  a n d  C R P 2  w e r e  e l u t e d  f r o m  th e  
c o lu m n  i n  a  0 - 2 5 0  m M  K C l g r a d i e n t .
R a t  C R P 3 /M L P  w a s  e x p r e s s e d  i n  b a c t e r i a  a s  a  H is - ta g g e d  f u s io n  
p r o t e in  (Q IA G E N  In c . ,  C h a t s w o r th ,  C A ). R a t  C R P 3 /M L P  i s  n e a r l y  9 0 %  
i d e n t i c a l  to  i t s  c h i c k e n  c o u n t e r p a r t  (1 9 ) . T h e  C R P 3 /M L P  b a c t e r i a l  e x ­
p r e s s io n  c o n s t r u c t ,  p Q E G -M L P , w a s  a  g e n e r o u s  g i f t  o f  S . A r b e r  a n d  P . 
C a r o n i  (1 4 ) . P u r i f i c a t i o n  o f  H is - ta g g e d  C R P 3 /M L P  w a s  p e r f o r m e d  fo l­
lo w in g  t h e  p r o to c o l  s u g g e s te d  b y  t h e  m a n u f a c t u r e r  (31 ).
B r a d f o r d  (B io -R a d )  a n d  L o w ry  ( P ie r c e )  p r o t e in  a s s a y s  w e r e  p e r ­
f o r m e d  to  e s t i m a t e  t h e  c o n c e n t r a t i o n s  o f  p u r i f i e d r e c o m b i n a n t  C R P s . I n  
b o th  a s s a y s ,  b o v in e  s e r u m  a l b u m in  w a s  u s e d  a s  a  s t a n d a r d .  T h e s e  
m e th o d s  y ie ld e d  c o m p a r a b le  q u a n t i t a t i v e  r e s u l t s .
Blot Overlay Assays— B lo t o v e r l a y  a s s a y s  w e r e  p e r f o r m e d  a s  d e ­
s c r ib e d  p r e v io u s ly  (9 , 2 1 , 2 2 , 3 2 ) . F o r  t h e s e  e x p e r i m e n t s ,  1 0 0  p m o l  o f  
C R P 1 , C R P 2 , a n d  C R P 3 /M L P  w e r e  r e s o lv e d  b y  S D S -P A G E  a lo n g  w i th  
t h e  c h i c k e n  g iz z a r d  f r a c t io n s  d e s c r ib e d  b e lo w . C o o m a s s ie  B lu e - s t a in e d  
g e l s  w e r e  a n a ly z e d  b y  d e n s i t o m e t r y  to  e v a l u a t e  t h e  r e l a t i v e  l e v e ls  o f  
p u r i f i e d  C R P s  p r e s e n t  o n  t h e  g e l .  P a r a l l e l  g e l s  w e r e  t r a n s f e r r e d  to  
n i t r o c e l lu lo s e  a n d  p r o b e d  w i t h  r a d i o a c t i v e ly  l a b e l e d  a - a c t i n i n  o r  z y x in  
p r o b e s  i n  b lo t  o v e r l a y  b u f f e r  (0 .5 %  b o v in e  s e r u m  a l b u m in ,  0 .2 5 %  g e l a ­
t i n ,  1 .0 %  N o n id e t  P -4 0 , 0 .1  m M  E D T A , 0 .1 %  2 - m e r c a p to e th a n o l ,  1 0  m M  
N a C l ,  a n d  2 0  m M  H e p e s  (p H  7 .5 )) . a- A c t in in  ( p u r i f i e d  f r o m  c h ic k e n  
g iz z a r d )  w a s  r a d i o io d in a t e d  u s i n g  p r e v io u s ly  d e s c r ib e d  m e th o d o lo g ie s  
(2 1 , 3 2 ) ;  2 5 0 ,0 0 0  c p m /m l 125I - la b e le d  c h i c k e n  a - a c t i n i n  w a s  in c lu d e d  i n  
e a c h  o v e r l a y  a s s a y .  T h e  z y x in  p r o b e  u s e d  i n  t h i s  s t u d y  w a s  a  r e c o m b i­
n a n t  32P - la b e le d  g l u t a t h i o n e  S- t r a n s f e r a s e  f u s io n  p r o t e in  c o n t a in i n g  
s e q u e n c e s  f r o m  t h e  z y x in  L IM  r e g i o n  ( c h ic k e n  z y x in  a m in o  a c id s  3 4 9 ­
5 4 2 ); t h i s  p r o b e  w a s  p r e v io u s ly  s h o w n  to  b e  s u f f ic i e n t  f o r  m e d i a t i n g  
in t e r a c t i o n s  w i t h  C R P 1  (9 ). G l u t a th io n e  S- t r a n s f e r a s e - z y x in  p ro b e s  
w e r e  in c lu d e d  i n  t h e  b lo t  o v e r l a y  b in d i n g  r e a c t i o n  a t  6 0 0 ,0 0 0  c p m /m l . 
A f t e r  a  2 - h  i n c u b a t i o n  w i t h  t h e  p r o b e s ,  b lo t s  w e r e  s u b s e q u e n t l y  w a s h e d  
a n d  e v a lu a t e d  b y  b o th  a u t o r a d i o g r a p h y  a n d  P h o s p h o r I m a g e r  a n a ly s i s  
( I m a g e q u a n t  s o f tw a r e ,  V e r s io n  3 .5 , M o le c u la r  D y n a m ic s ,  In c . ,  S u n n y ­
v a l e ,  C A ). R e la t i v e  C R P  b in d i n g  a c t iv i t i e s  w e r e  n o r m a l i z e d  to  p r o t e in  
le v e ls  d e t e r m i n e d  b y  d e n s i t o m e t r y ;  t h e s e  v a l u e s  a r e  p r e s e n t e d  h e r e  a s  
a  p e r c e n ta g e  o f  t h e  b in d i n g  o b s e r v e d  f o r  C R P 1  ±  S .E .
SDS-PAGE and Western Immunoblotting— S D S -P A G E  w a s  p e r ­
f o r m e d  a c c o r d in g  to  t h e  m e th o d  o f  L a e m m li  (3 3 )  w i t h  a  b i s a c r y la m id e  
c o n c e n t r a t i o n  o f  0 .1 3 % . 1 5 %  g e l s  w e r e  u t i l i z e d  to  r e s o lv e  a l l  C R P -  
c o n t a in i n g  s a m p l e s  e x a m in e d  i n  t h i s  s t u d y .  M o le c u la r  m a s s  m a r k e r s  
(B io -R a d )  c o r r e s p o n d  to  m y o s in  (2 0 0  k D a ) ,  ^ - g a l a c t o s i d a s e  (1 1 6  k D a ) ,  
p h o s p h o r y la s e  b (9 7  k D a ) ,  s e r u m  a l b u m i n  (6 6  k D a ) ,  o v a lb u m in  (4 3  


























ly s o z y m e  (1 4  k D a ) .  W e s t e r n  im m u n o b lo t  a n a ly s e s  w e r e  p e r f o r m e d  fo l­
lo w in g  t h e  p ro to c o ls  d e v e lo p e d  b y  T o w b in  et al. (3 4 )  u s in g  h o r s e r a d i s h  
p e ro x id a s e - c o u p le d  p r o t e in  A  a s  a  s e c o n d a r y  a g e n t .  D e te c t io n  w a s  p e r ­
f o r m e d  v i a  c h e m i l u m in e s c e n t  t e c h n iq u e s  (E C L , A m e r s h a m  L ife  S c i ­
e n c e ,  In c .) .
Antibody Production— Is o fo rm -s p e c if ic  a n t i p e p t i d e  a n t ib o d ie s  w e r e  
g e n e r a t e d  f o r  c h i c k e n  C R P 1 , C R P 2 , a n d  C R P 3 /M L P . U n iq u e  p e p t id e s  
f r o m  d iv e r g e n t  r e g io n s  w i t h i n  e a c h  C R P  w e r e  i d e n t i f i e d  a c c o r d in g  to  
t h e  c r i t e r i a  o f  D o o li t t le  (3 5 ) . T h e  e x a c t  p e p t id e  s e q u e n c e s  w e r e  a s  
fo llo w s : C R P 1 , K Y E E G Q S H R P T N P N A S R M  ( a m in o  a c id s  9 1 - 1 0 8 ) ;  
C R P 2 , K P E S T P S P H R P T T N P N T S K F  ( a m in o  a c id s  9 1 - 1 1 0 ) ;  a n d  C R P 3 /  
M L P , F G G L T Q V E K K E  ( a m in o  a c id s  1 8 4 - 1 9 4 ) .  P e p t i d e s  w e r e  s y n t h e ­
s iz e d  u s in g  a n  A p p l ie d  B io s y s te m s  M o d e l 4 3 1 A  p e p t id e  s y n th e s i z e r .  
E a c h  p e p t id e  w a s  s u p p le m e n te d  w i t h  a n  a m in o - t e r m in a l  c y s te in e  to  
a l lo w  f o r  s u b s e q u e n t  c o u p l in g  to  b o v in e  s e r u m  a l b u m in  ( S ig m a )  o r  to  
k e y h o le  l i m p e t  h e m o c y a n in  ( S ig m a )  c a r r i e r  p r o t e in s  (3 5 ) . C h e m ic a l  
c o u p l in g  to  b o v in e  s e r u m  a l b u m in  o r  k e y h o le  l i m p e t  h e m o c y a n in  w a s  
p e r f o r m e d  u s i n g  m- m a le im id o b e n z o y l-N- h y d r o x y s u c c in im id e  e s t e r  
( P ie r c e )  a s  d e s c r i b e d  p r e v io u s ly  (3 6 ) . C a r r i e r - c o u p le d  p e p t id e s  w e r e  
i n j e c t e d  in t o  N e w  Z e a la n d  W h i te  r a b b i t s ,  a n d  i m m u n e  s e r a  w e r e  co l­
l e c t e d  f o l lo w in g  e s t a b l i s h e d  p ro to c o ls  (3 7 ). C R P 1 - , C R P 2 - , a n d  C R P 3 /  
M L P -s p e c if ic  a n t i s e r a  a r e  r e f e r r e d  to  b e lo w  a s  a n t i - C R P 1 ,  a n t i - C R P 2 ,  
a n d  a n t i - C R P 3 ,  r e s p e c t iv e ly .  A  p r e v io u s ly  d e s c r ib e d  a n t i - z y x i n  a n t i ­
b o d y , c a l le d  B 3 8  (3 8 ) , w a s  a l s o  u s e d  i n  W e s t e r n  im m u n o b lo t  a n a ly s e s .
Embryonic Chicken Organ/Tissue Sample Preparation— S e le c te d  
e m b r y o n ic  c h i c k e n  o r g a n s  a n d  t i s s u e s  w e r e  p r e p a r e d  a n d  h o m o g e n iz e d  
a s  d e s c r i b e d  p r e v io u s ly  (3 0 ) . B r ie f ly ,  1 9 - d a y  c h ic k  e m b r y o s  w e r e  d i s ­
s e c t e d  to  r e c o v e r  p r o t e in  s a m p l e s  f r o m  h e a r t ,  s to m a c h ,  b r a i n ,  c ro p , 
l i v e r ,  a r t e r i e s ,  g iz z a r d ,  lu n g ,  in t e s t in e /c o lo n ,  le g  s k e l e t a l  m u s c le ,  a n d  
f ib r o b l a s t s .  F o r  d e v e lo p m e n t a l  t i m e  c o u r s e  s tu d i e s ,  g i z z a r d s ,  a r t e r i e s ,  
a n d  h e a r t s  w e r e  e x t r a c t e d  f r o m  11 -, 13 -, 15 -, a n d  1 8 -d a y  e m b ry o s .  
S a m p le s  f r o m  e a c h  o r g a n / t i s s u e  w e r e  h o m o g e n iz e d  r a p i d l y  i n  d i s t i l l e d  
H 2O  c o n t a in i n g  1 m M  p h e n y l m e t h y ls u l f o n y l  f lu o r id e  ( S ig m a )  a t  a  r a t i o  
o f  5 m l o f  h o m o g e n iz a t io n  b u f f e r /g  o f  o r g a n  o r  t i s s u e  (w e t  w e ig h t ) .  
S a m p le s  w e r e  p r e p a r e d  f o r  S D S -P A G E  i n  L a e m m li  s a m p l e  b u f f e r  (3 3 ); 
D N A  w a s  s h e a r e d  b y  p a s s in g  s a m p l e s  t h r o u g h  a  2 6 - g a u g e  s y r in g e .  
S a m p le s  w e r e  b o ile d  f o r  4  m i n  p r io r  to  lo a d in g  o n to  g e l s .  10  ^ l  o f  e a c h  
s a m p l e  w e r e  l o a d e d  p e r  la n e .
P r o t e i n  e x t r a c t s  u s e d  i n  t h e  b lo t  o v e r l a y  a s s a y s  w e r e  o b t a in e d  f ro m  
a d u l t  c h i c k e n  g i z z a r d s  a s  d e s c r i b e d  p r e v io u s ly  (1 8 , 3 9 ) . W h o le  g i z z a r d  
e x t r a c t s  w e r e  s e q u e n t i a l l y  p r e c i p i t a t e d  w i t h  i n c r e a s i n g  c o n c e n t r a t io n s  
o f  a m m o n iu m  s u l f a t e  to  g iv e  r i s e  to  tw o  d i f f e r e n t  c o m p le x  p r o t e in  
f r a c t i o n s ,  o n e  ( f ro m  a  3 4 - 4 3 %  p r e c i p i t a t i o n )  t h a t  c o n t a in e d  C R P  a n d  
o n e  ( f ro m  a  4 3 - 6 1 %  p r e c i p i t a t i o n )  t h a t  d id  n o t .  P r e c i p i t a t e d  p r o t e in  
f r a c t i o n s ,  o n c e  r e s u s p e n d e d ,  w e r e  d i l u t e d  1 :2  i n  2 X L a e m m li  s a m p le  
b u f f e r  a n d  b o i le d  f o r  3  m in .  10  ^ l  o f  e a c h  f r a c t i o n  w e r e  lo a d e d  p e r  l a n e  
o n to  d e n a t u r i n g  g e ls .
R E S U L T S
Recent studies have revealed the existence of three proteins, 
called CRP1, CRP2, and CRP3/MLP, that are members of a 
family of highly conserved gene products (1, 15-19). CRP fam­
ily members are characterized by the presence of two tandemly 
arrayed zinc-binding LIM domains, each of which is followed by 
a conserved glycine-rich repeat (Fig. 1A) (1, 2, 18). Pairwise 
comparisons of the three CRPs show that these molecules are 
very similar to each other, exhibiting >65% amino acid se­
quence identity (Fig. 1, B  and C). The similarity of these three 
proteins, in combination with data implicating CRPs in muscle 
function (18, 20 , 26), raises a number of questions regarding 
the physiological significance of the existence of multiple CRP 
isoforms. We were interested in determining whether the three 
CRPs display distinct functions or expression patterns. We 
have analyzed the biochemical and cellular functions of each 
CRP family member by examining their subcellular localiza­
tions and binding-partner preferences. We have also examined 
CRP expression patterns in various embryonic chicken organs.
Subcellular D istribution  o f CRP F am ily M em bers in Cul­
tured F ibroblasts—We first explored the possibility that the 
three CRP family members display distinct subcellular local­
izations. Classically, localization studies are performed by in­
direct immunofluorescence. However, because available CRP 
isoform-specific antibodies fail to recognize native CRPs in 
fixed and permeabilized cells, we monitored the subcellular
localization patterns of CRP1, CRP2, and CRP3/MLP by tran­
siently expressing epitope-tagged versions of the proteins.
Three mammalian expression constructs were generated, 
each encoding one of the chicken CRPs. CRPs expressed from 
these vectors contained a C-terminal c-Myc epitope tag that 
allowed for the detection of heterologously expressed CRPs 
within the transfected cells. Purified expression constructs 
were inj'ected into the nuclei of adherent REF52 cells, a fibro­
blastic cell line known for its well organized actin filament 
arrays (40, 41). After a 24-h incubation, CRP expression was 
visualized in the cells by indirect immunofluorescence using an 
anti-Myc antibody. The three different CRP isoforms exhibited 
similar subcellular localizations (Fig. 2). Each protein colocal­
ized with filamentous actin; some punctate cytoplasmic stain­
ing was also observed. No staining was detected in cells in­
jected with a control vector lacking CRP sequences (data not 
shown). Contrary to previous reports for CRP2 (20) and CRP3/ 
MLP (14), we did not consistently observe accumulation of any 
of the three CRP isoforms in the nuclei of these cells. The 
cytoskeletal staining patterns observed here were comparable 
to those observed in previous experiments that used polyclonal 
antisera to detect endogenous CRP (18). Thus, the subcellular 
distributions observed in this study with ectopically expressed 
CRPs are likely to be physiologically relevant.
Characterization o f  CRP B inding-partner Preferences—Pre­
vious studies have demonstrated that the CRP1 protein inter­
acts specifically with two cytoskeletal proteins, a-actinin (2 1 ) 
and zyxin (9, 16). To determine whether each of the three CRP 
isoforms is capable of interacting with these protein partners, 
we performed in vitro  binding assays. For these studies, 
equimolar amounts of purified recombinant CRP1, CRP2, and 
CRP3/MLP were resolved by SDS-PAGE (Fig. 3A, lanes 1-3). 
Two complex fractions derived from a chicken gizzard extract 
were also included on the gel (Fig. 3A, lanes 4 and 5); the 
fraction resolved in lane 4 contains CRP, whereas the fraction 
in lane 5  does not. Parallel gels were transferred to nitrocellu­
lose and probed with one of two purified radiolabeled proteins: 
125I-labeled a-actinin or 32P-labeled zyxin. The a-actinin probe 
was purified from avian smooth muscle; the zyxin probe, con­
taining sequences from the zyxin C-terminal LIM region, was 
generated as a glutathione S -transferase fusion protein in bac­
teria (Fig. 3D ). Autoradiographic analysis of the blot overlay 
assays revealed that all three CRP isoforms were capable of 
interacting with both the a-actinin and zyxin protein probes 
(Fig. 3, B  and C, respectively). 32P-Labeled glutathione S- 
transferase did not interact with any proteins present on the 
blot (Refs. 9 and 22; data not shown). Moreover, the probes 
utilized in these studies failed to interact with other proteins 
present in the smooth muscle fractions (Fig. 3, A -C , lanes 4 and 
5 ; data not shown), suggesting that the observed interactions 
are specific. Quantitation of these data revealed that the a - 
actinin probe bound each CRP family member at comparable 
levels (Fig. 3E ); similar results were obtained with the zyxin 
probe (Fig. 3E). These findings demonstrate that CRP1, CRP2, 
and CRP3/MLP have common biochemical activities.
A ntipeptide A ntibody Design an d  Characterization—As de­
scribed above, CRP family members cannot be distinguished 
from each other based on their subcellular distributions or 
their binding-partner preferences. In the following studies, we 
examined the possibility that the CRPs exhibit unique patterns 
of protein expression. Due to the overall sequence conservation 
of CRP1, CRP2, and CRP3/MLP, we reasoned that previously 
generated polyclonal antibodies were likely to recognize 
epitopes common to multiple CRPs, thereby precluding their 
use in comparative Western immunoblot analyses (18, 21). 
























F ig .  1. T h e  c h i c k e n  C R P  m u l t i g e n e  
f a m i l y  i s  c o m p o s e d  o f  t h r e e  h i g h l y  
c o n s e r v e d  p r o t e i n s .  A , t h e  m o le c u la r  
a r c h i t e c t u r e  o f  C R P  f a m i ly  m e m b e r s  is  
c h a r a c t e r i z e d  b y  t h e  p r e s e n c e  o f  tw o  z in c -  
b in d i n g  L IM  d o m a in s ,  e a c h  o f  w h ic h  is  
f o llo w e d  b y  a  c o n s e r v e d  g ly c in e - r ic h  r e ­
p e a t .  B, p a i r w i s e  c o m p a r i s o n s  w e r e  m a d e  
b e t w e e n  c h i c k e n  C R P  s e q u e n c e s ,  a n d  
i d e n t i t i e s  w e r e  d e t e r m i n e d  a c c o r d in g  to  
t h e  p a r a m e t e r s  s e t  b y  L i p m a n  a n d  P e a r ­
s o n  (5 4 ) . C o lle c t iv e ly ,  t h i s  a n a ly s i s  d e m ­
o n s t r a t e s  t h a t  C R P 1 , C R P 2 , a n d  C R P 3 / 
M L P  s h a r e  a  h i g h  d e g r e e  o f  s e q u e n c e  
i d e n t i t y .  C, s e q u e n c e  a l i g n m e n t  o f  a l l  
t h r e e  c h i c k e n  C R P  a m in o  a c id  s e q u e n c e s  
i l l u s t r a t e s  t h e  s p e c if ic  r e g io n s  w i t h i n  
t h e s e  p r o t e in s  t h a t  s h a r e  t h e  h i g h e s t  d e ­
g r e e  o f  s im i l a r i t y .  Black boxes d e n o t e  r e s ­
id u e s  t h a t  a r e  a b s o lu t e ly  i d e n t i c a l  b e ­
t w e e n  t h e  t h r e e  m o le c u le s ;  gray boxes 
in d i c a t e  t h o s e  r e s id u e s  t h a t ,  w h i le  n o t  
i d e n t i c a l  b e t w e e n  a l l  t h r e e  p r o t e in s ,  d i s ­
p l a y  n o ta b l e  s e q u e n c e  s i m i l a r i t y  ( s i m i l a r ­
i t y  g r o u p s  w e r e  a s s ig n e d  a s  d e s c r ib e d  p r e ­
v io u s ly  (1 ): A la ,  S e r ,  T h r ;  A s p , G lu ; A s n ,  
G in ; A rg , L y s ; I le ,  L e u ,  M e t ,  V a l;  P h e ,  T y r ,  
T r p ) .  T h e  c h i c k e n  C R P 3 /M L P  s e q u e n c e  
s h o w n  h e r e  d i f f e r s  i n  f o u r  p o s i t i o n s  f ro m  
t h e  o r ig in a l ly  r e p o r t e d  s e q u e n c e  ( a t  
a m in o  a c id s  9 2 , 9 3 , 9 4 , a n d  1 1 4 )  (1 9 ) . T h e  
c o r r e c t io n s  to  t h e  C R P 3 /M L P  s e q u e n c e  
t h a t  a r e  r e p o r t e d  h e r e  r e s u l t  i n  s l ig h t ly  
g r e a t e r  d e g r e e s  o f  s i m i l a r i t y  b e tw e e n  
C R P  is o fo rm s  t h a n  w e r e  d e s c r i b e d  p r e v i ­
o u s ly  (1 , 19). D ,  s h o w n  a r e  t h e  is o fo rm -  
s p e c if ic  p e p t id e  s e q u e n c e s  t h a t  w e r e  u s e d  
to  g e n e r a t e  a n t ib o d ie s  a g a i n s t  e a c h  o f  t h e  
C R P  f a m i ly  m e m b e r s .  aa, a m in o  a c id s .
it was necessary to generate isoform-specific anti-CRP antibod­
ies for use in this study.
To develop isoform-specific reagents, we identified divergent 
regions within each CRP family member and synthesized pep­
tides corresponding to the distinguishing sequences (Fig. 1D ). 
All peptides chosen were <55% identical to sequences occupy­
ing similar positions in the other two molecules. Specifically, 
the selected CRP1 and CRP2 peptides, derived from the same 
region in the molecule, are 55% identical (65% similar) to each 
other. While the CRP1 peptide is only 24% identical (33% 
similar) to corresponding CRP3/MLP sequences, the CRP2 pep­
tide sequence is 43% identical (48% similar). Finally, the CRP3/ 
MLP peptide displays 25% identity (33% similarity) and 17% 
identity (33% similarity) to corresponding CRP1 and CRP2 
sequences, respectively. These peptides were coupled to carrier 
molecules and used as immunogens. CRP-specific antipeptide 
antibodies were raised in rabbits, and antisera were character­
ized by Western immunoblot analysis (Fig. 4).
To characterize the specificity of the antipeptide antibodies, 
equimolar amounts of purified recombinant CRP1, CRP2, and 
CRP3/MLP, as well as a sample of embryonic chicken gizzard 
extract, were resolved by SDS-PAGE and visualized by Coo-
massie Blue staining. As shown in Fig. 4A , each of the three 
CRPs was loaded at comparable levels onto the gel. The faint 
16-kDa band observed in the CRP2 preparation is a proteolytic 
product of the purified protein (Fig. 4A , lane 3 ). Parallel gels 
were transferred to nitrocellulose and probed with each of the 
anti-CRP antibodies and their corresponding preimmune sera 
(Fig. 4, B -D ).
The Western immunoblots in Fig. 4 demonstrate that the 
isoform-specific antipeptide antibodies are in fact capable of 
distinguishing between each of the three CRP family members. 
The anti-CRP1 antibody bound to purified CRP1, but failed to 
interact with CRP2 or CRP3/MLP at the dilution used (Fig. 4B, 
lanes 2 -4 ) . (At a higher concentration, this antibody did show 
some affinity for CRP2 (data not shown).) The anti-CRP2 se­
rum specifically recognized purified CRP2 (appearing on the 
blot as a doublet that is likely to be due to incomplete sample 
reduction) as well as the CRP2 degradation product visualized 
faintly on the Coomassie Blue-stained gel (Fig. 4, A  and C , 
lanes 3 ). Finally, the anti-CRP3 antibody recognized CRP3/ 
MLP, but not CRP1 or CRP2 (Fig. 4D, lane 4). In all cases, the 
preimmune sera failed to interact with any of the three purified 
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F ig . 2. A l l  t h r e e  C R P  f a m i l y  m e m b e r s  a s s o c i a t e  w i t h  t h e  a c t i n  
c y t o s k e l e t o n  i n  a d h e r e n t  f i b r o b l a s t s .  R E F 5 2  c e l ls  w e r e  m i c r o in ­
j e c t e d  w i t h  e x p r e s s io n  c o n s t r u c t s  e n c o d in g  M y c - ta g g e d  C R P 1  (A  a n d  B ), 
C R P 2  (C  a n d  D ) ,  a n d  C R P 3 /M L P  (E  a n d  F). A f t e r  a  2 4 -h  i n c u b a t i o n  a t  
3 7  °C , c e l ls  w e r e  p r o c e s s e d  f o r  im m u n o f lu o r e s c e n c e  u s in g  a n t i -M y c  
a n t ib o d ie s  to  v i s u a l iz e  M y c - ta g g e d  C R P s  (A , C , a n d  E )  o r  u s in g  r h o -  
d a m in e - c o n j u g a te d  p h a l lo id i n  to  v i s u a l iz e  f i l a m e n to u s  a c t i n  (B , D , a n d  
F ) .  E a c h  o f  t h e  t h r e e  C R P s  c o lo c a liz e s  w i t h  a c t i n  f i l a m e n t s  i n  th e  
R E F 5 2  c e lls .  A  p u n c t a t e  p a t t e r n  t h a t  d o e s  n o t  c o d i s t r i b u t e  w i t h  th e  
a c t i n  f i l a m e n t s  i s  a l s o  o b s e r v e d  f o r  a l l  t h r e e  C R P  f a m i ly  m e m b e r s .  T h e  
s ig n if i c a n c e  o f  t h i s  p u n c t a t e  s t a i n i n g  i s  n o t  c l e a r ;  i t  c o u ld  r e p r e s e n t  a n  
a s s o c i a t i o n  o f  C R P s  w i t h  s o m e  s m a l l  o r g a n e l le ,  o r  i t  m a y  r e p r e s e n t  
p r o t e in  a g g r e g a t e s  t h a t  r e s u l t  u p o n  o v e r e x p r e s s io n  o f  C R P s . S in c e  t h e  
c e l ls  w e r e  t r a n s i e n t l y  t r a n s f e c t e d ,  w e  d o  n o t  k n o w  t h e  c o n c e n t r a t i o n  o f  
C R P  p r o t e in  e x p r e s s e d  i n  t h e  s a m p le ;  t h e r e f o r e ,  i t  i s  n o t  p o s s ib le  to  
a s s e s s  w h e t h e r  w e  h a v e  s a t u r a t e d  a l l  C R P - b in d in g  s i t e s .  Bar = 3 2  ^ m .
smooth muscle extract lanes (Fig. 4, B -D , lanes 1 '-4 '), Inter­
estingly, of the three isoform-specific antibodies, only the anti- 
CRP1 antibody recognized a 23-kDa CRP in the complex 
chicken gizzard extract (Fig. 4, B -D , lanes 1). This result pro­
vided the first indication that CRP family members would 
exhibit distinct expression patterns.
O rgan /T issu e D istribution  o f  CRP F am ily M embers—CRP 
isoform-specific antibodies were used in Western immunoblot 
analyses to screen protein extracts derived from 19-day chicken 
embryos. Proteins from chicken embryo brain, heart, arteries, 
crop, stomach, gizzard, intestine/colon, skeletal muscle, liver, 
lung, and fibroblasts were resolved by SDS-PAGE. The Coo­
massie Blue-stained gel in Fig. 5A illustrates the protein com­
plexity of each organ or tissue. Parallel gels were analyzed by 
Western immunoblotting using each of the CRP isoform-spe­
cific antibodies described above (Fig. 5, B -D ) as well as an 
antibody specific for the CRP binding partner zyxin (Fig. 5E) 
(38). This analysis revealed that each CRP family member 
exhibits a distinct expression pattern. CRP1 is found predom­
inantly in organs enriched in smooth muscle, including arter­
ies, stomach, gizzard, and intestine/colon, as well as in lung 
and fibroblasts (Fig. 5B, lanes 3, 5 -7 , 10, and 11). CRP2 ex­
pression is limited to arteries and fibroblasts (Fig. 5C, lanes 3 
and 11), and CRP3/MLP is present exclusively in heart, crop, 
and skeletal muscle (Fig. 5D, lanes 2, 4, and 8). Using the 
anti-CRP3 antibody, we sometimes observed two immunoreac- 
tive polypeptides in heart and skeletal muscle: one migrated as 
expected at 23 kDa, and the other migrated at 33 kDa (Fig. 5D, 
lanes 2  and 8). The significance of this additional band is 
currently unclear, but it appears to occur only in very late 
stages of chick development. With the exception of the crop, the 
CRP binding partner zyxin is observed in all organs and tissues 
containing at least one CRP family member (Fig. 5E). Collec-
F ig . 3 . C R P 1 ,  C R P 2 ,  a n d  C R P 3 / M L P  e x h i b i t  s i m i l a r  b i n d i n g -  
p a r t n e r  p r e f e r e n c e s .  A , C o o m a s s ie  B lu e - s t a in e d  g e l  i l l u s t r a t i n g  p r o ­
t e i n s  u s e d  i n  t h e  b lo t  o v e r l a y  a s s a y .  Lanes 1-3 w e r e  lo a d e d  w i t h  1 0 0  
p m o l  o f  p u r i f i e d  r e c o m b in a n t  c h i c k e n  C R P 1 , c h i c k e n  C R P 2 , a n d  r a t  
C R P 3 /M L P , r e s p e c t iv e ly .  Lanes 4 a n d  5 w e r e  l o a d e d  w i t h  tw o  d i f f e r e n t  
a m m o n iu m  s u l f a t e  p r e c i p i t a t i o n  f r a c t i o n s  d e r i v e d  f ro m  a  c h i c k e n  g iz ­
z a r d  l y s a t e .  T h e  e x t r a c t  i n  lane 4 c o n t a in s  C R P , w h e r e a s  t h e  e x t r a c t  i n  
lane 5 d o e s  n o t .  B a n d  C , a u t o r a d io g r a p h i c  a n a ly s i s  o f  p a r a l l e l  g e l s  t h a t  
w e r e  t r a n s f e r r e d  to  n i t r o c e l lu lo s e  a n d  p r o b e d  i n  b lo t  o v e r l a y  a s s a y s  
w i t h  125I - la b e le d  a - a c t i n i n  a n d  32P - la b e le d  z y x in , r e s p e c t iv e ly .  D ,  a u t o ­
r a d i o g r a p h  d e m o n s t r a t i n g  t h e  h o m o g e n e i ty  o f  t h e  r a d i o l a b e l e d  a - a c t i -  
n i n  a n d  z y x in  p r o b e s .  E ,  b lo t  o v e r l a y  a s s a y s  q u a n t i t a t e d  b y  P h o s p h o r  
I m a g e r  a n a ly s i s .  Q u a n t i t a t i v e  d a t a  f r o m  t h r e e  i n d e p e n d e n t  
e x p e r i m e n t s  w e r e  n o r m a l iz e d  r e l a t i v e  to  t h e  a m o u n t  o f  p r o t e in  p r e s e n t  
o n  t h e  b lo t ,  a s  d e t e r m i n e d  b y  d e n s i t o m e t r i c  a n a ly s i s  o f  p a r a l l e l  C oo- 
m a s s i e  B lu e - s t a in e d  g e l s .  T h e s e  n o r m a l i z e d  v a l u e s  h a v e  b e e n  e x p r e s s e d  
h e r e  a s  a  p e r c e n ta g e  o f  t h e  m a x im a l  b in d i n g  o b s e r v e d  f o r  t h e  C R P 1  
p r o t e in  ±  S .E . C o lle c t iv e ly ,  t h e s e  r e s u l t s  d e m o n s t r a t e  t h a t  a - a c t in i n  
a n d  z y x in  a r e  c a p a b le  o f  i n t e r a c t i n g  a t  c o m p a r a b le  l e v e ls  w i t h  e a c h  o f  
t h e  C R P s .
tively, these results demonstrate that each of the three CRP 
family members has a distinct expression profile (Table I).
Developm ental Expression P atterns o f CRP F am ily Mem- 
bers—Having demonstrated that CRP family members display 
spatially distinct patterns of expression, we next explored the 
possibility that these proteins may also exhibit temporal vari­
ation in their expression patterns during embryogenesis. We 
utilized the isoform-specific antibodies to monitor CRP expres­
sion levels in organs extracted from 11-, 13-, 15-, and 18-day 
chick embryos. Based on the organ-specific expression patterns 
observed above, we chose to evaluate CRP1 in gizzard and 
arteries, CRP2 in arteries, and CRP3/MLP in heart. Proteins 
from the selected organs were visualized by Coomassie Blue 
staining of SDS-polyacrylamide gels (Fig. 6). Parallel gels were 
transferred to nitrocellulose and analyzed by Western immu- 
noblotting. As observed in previous studies (18), CRP1 levels 
were shown to increase gradually as a function of developmen­
tal time in both chicken gizzard and arteries (Fig. 6, A  and B). 
In contrast, the level of CRP2 in arteries increased markedly 
between days 11 and 13 of development; CRP2 expression 
remained constant between days 13 and 18 (Fig. 6B). CRP3/ 
MLP expression levels were constant in embryonic heart at the 
developmental stages examined (Fig. 6C). Therefore, in addi­
tion to exhibiting spatially distinct patterns of expression in 
embryos, CRP family members also display differences in their 
temporal regulation during development.
D IS C U S S IO N
Recent studies revealing the sequence similarity of CRP1, 
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1 2  3 4 
a n t i - C R P I
1’ 2'  3’ 4'  
preimmune
•
1 2  3 4 
anti-CRP2
1’ 2’ 3'  4’ 
preimmune
-
1 2  3 4 
anti-CRP3
T 2’ 3’ 4‘ 
preimmune
F ig . 5. C R P  f a m i l y  m e m b e r s  e x h i b i t  d i s t i n c t  p a t t e r n s  o f  e x ­
p r e s s i o n .  S h o w n  i s  a  C o o m a s s ie  B lu e - s t a in e d  g e l  i l l u s t r a t i n g  t h e  p r o ­
t e i n s  p r e s e n t  i n  s a m p l e s  p r e p a r e d  f r o m  a  1 9 - d a y  c h i c k e n  e m b ry o  (A ). 
W e s t e r n  im m u n o b lo t  a n a ly s e s  w e r e  p e r f o r m e d  o n  p a r a l l e l  b lo t s  u s in g  
i s o f o rm -s p e c i f ic  a n t i - C R P  a n t ib o d ie s  (B-D) o r  u s in g  a n  a n t i - z y x i n  a n t i ­
b o d y  (E ) . T h e s e  e x p e r i m e n t s  d e m o n s t r a t e  t h a t  C R P 1  i s  e x p r e s s e d  p r e ­
d o m i n a n t l y  i n  a r t e r i e s ,  s t o m a c h ,  g i z z a r d ,  i n t e s t i n e / c o l o n ,  lu n g ,  a n d  
f i b r o b l a s t s  (B ); t h a t  C R P 2  i s  o b s e r v e d  p r i m a r i l y  i n  a r t e r i e s  a n d  f ib r o ­
b l a s t s  (C); a n d  t h a t  C R P 3 /M L P  e x p r e s s io n  i s  l i m i t e d  to  h e a r t ,  c ro p ,  a n d  
s k e l e t a l  m u s c l e  (D ). W i th  t h e  e x c e p t io n  o f  t h e  c ro p , t h e  C R P  b in d in g  
p a r t n e r  z y x in  i s  c o e x p re s s e d  w i t h  a t  l e a s t  o n e  C R P  f a m i ly  m e m b e r  i n  
e v e r y  o r g a n / t i s s u e  e x a m in e d  (E ).
T a b l e  I
Expression of CRPs in embryonic chicken organs and tissues
F ig . 4 . C h a r a c t e r i z a t i o n  o f  C R P  i s o f o r m - s p e c i f i c  a n t i p e p t i d e  
a n t i b o d i e s .  G e ls  f o r  u s e  i n  W e s t e r n  im m u n o b lo t  a n a ly s e s  w e r e  lo a d e d  
a s  fo llo w s : lane M, m o l e c u l a r  m a s s  m a r k e r s ;  lane 1, e m b r y o n ic  c h i c k e n  
s m o o th  m u s c l e  e x t r a c t ;  lane 2, p u r i f i e d  r e c o m b in a n t  C R P 1 ; lane 3, 
p u r i f i e d  r e c o m b in a n t  C R P 2 ; lane 4, p u r i f i e d  r e c o m b in a n t  C R P 3 /M L P . 
P r o t e i n s  w e r e  v i s u a l i z e d  i n  A b y  C o o m a s s ie  B lu e  s t a i n in g .  P a r a l l e l  g e ls  
w e r e  t r a n s f e r r e d  to  n i t r o c e l lu lo s e  a n d  p r o b e d  w i t h  a n t i - C R P 1  (B ), a n t i -  
C R P 2  (C ), a n d  a n t i - C R P 3  (D ) a n t ib o d ie s  o r  w i t h  t h e i r  c o r r e s p o n d in g  
p r e i m m u n e  s e r a  ( B -D ,  lanes 1 - 4 ' ) .  T h e s e  d a t a  i l l u s t r a t e  t h a t  t h e  
a n t i p e p t i d e  a n t ib o d ie s  g e n e r a t e d  h e r e  a r e  C R P  is o fo rm -s p e c i f ic .  T h e  
a n t i - C R P 1  a n t ib o d y  i s  t h e  o n ly  a n t ib o d y  t h a t  r e c o g n iz e s  a  2 3 - k D a  b a n d  
i n  t h e  e m b r y o n ic  s m o o th  m u s c l e  e x t r a c t .
regarding the physiological and biological significance of the 
CRP multigene family. In this report, we have compared the 
subcellular distributions, biochemical properties, and expres­
sion patterns of three vertebrate CRPs. Transient expression of 
epitope-tagged CRP1, CRP2, and CRP3/MLP in rat embryo 
fibroblasts revealed that all three CRP isoforms associate with 
the actin cytoskeleton. Moreover, all three proteins have the 
capacity to bind a-actinin and zyxin. Together, these observa-
O rgan /T issue CRP1 CPR2 CPR3/MLP Zyxin
B r a i n —a — — —
H e a r t — — + +
A r te r i e s + + — +
C ro p — — + —
S to m a c h + — — +
G iz z a r d + — — +
In te s t in e / c o lo n + — — +
S k e le t a l  m u s c l e — — + +
L iv e r — — — —
L u n g + — — +
F ib r o b la s t + + — +
a —, n o  p r o t e in  e x p r e s s io n  d e t e c te d ;  + ,  d e t e c t a b l e  l e v e ls  o f  p r o t e in  
e x p r e s s io n  a b o v e  b a c k g ro u n d .
tions suggest that the three CRP family members display sim­
ilar biochemical properties and subcellular distributions.
In contrast, significant differences among the CRPs are evi­
dent in their temporal and spatial patterns of expression. In 
chicken, the distribution of CRP isoforms appears to be largely 
restricted to organs containing muscle cell tissue, thereby im­
plying a general role for the CRP multigene family in muscle 
function. We detected CRP3/MLP in avian heart and skeletal 
muscle, a finding consistent with the demonstration that 
CRP3/MLP is necessary for the differentiation of cardiac and 
skeletal muscle cells in the mouse (26). We also found CRP3/ 
MLP in the crop, an organ unique to avian species that is 




























F ig . 6 . C R P  f a m i l y  m e m b e r s  d i s p l a y  d i f f e r e n t  p a t t e r n s  o f  d e ­
v e l o p m e n t a l  r e g u l a t i o n .  G iz z a r d s ,  a r t e r i e s ,  a n d  h e a r t s  w e r e  e x ­
t r a c t e d  f r o m  c h ic k  e m b r y o s  f r o m  f o u r  d e v e lo p m e n t a l  s t a g e s :  1 1 , 13 , 15 , 
a n d  18  d a y s .  T h e  upper panels i n  A-C s h o w  C o o m a s s ie  B lu e - s t a in e d  
g e l s ,  i l l u s t r a t i n g  t h e  p r o t e in  p r o f i l e s  o f  e m b r y o n ic  g iz z a r d ,  a r t e r i e s ,  a n d  
h e a r t .  P a r a l l e l  g e l s  w e r e  t r a n s f e r r e d  to  n i t r o c e l lu lo s e  a n d  a n a ly z e d  b y  
W e s t e r n  im m u n o b lo t t i n g  u s i n g  t h e  i s o f o rm -s p e c i f ic  a n t i - C R P  a n t ib o d ­
i e s  (lower panels i n  A-C).
while CRP1 and CRP2 are not found in organs containing 
striated muscle, they are prominent in a variety of tissues rich 
in smooth muscle. For example, CRP1 is detected in gizzard, 
stomach, intestine/colon, arteries, and lung, all of which con­
tain substantial amounts of smooth muscle tissue (45). CRP1 is 
also present in fibroblasts, which are smooth muscle-like in 
terms of their protein expression patterns. CRP2 is expressed 
in a subset of these organs, specifically in arteries and fibro­
blasts; while this manuscript was in preparation, Jain et al. 
(20) described the expression of CRP2 (also referred to as 
SmLIM) in ra t aortic smooth muscle. We suspect that immu- 
nocytochemical analysis will reveal that CRP1 and CRP2 are 
generally present in the vasculature, but that we do not have 
the sensitivity to detect them in whole organ samples, except in 
isolated arteries. High resolution immunocytochemical or in 
situ  hybridization studies will be essential to identify the cell 
types within arteries (for example) that express each CRP 
isoform. Such an analysis of early embryonic stages would also 
allow us to define the point at which tissue-restricted expres­
sion of CRP isoforms occurs. In general, CRP family members 
may serve as markers for different types of muscle. Consistent 
with findings for vertebrate CRPs, two CRP family members 
identified in Drosophila  also exhibit muscle-specific expression 
(2, 19).
Based on the fact that CRP family members have many 
functions in common and no unique functions detected thus far, 
it is reasonable to speculate that these proteins may play 
similar roles in cells. One possibility is that CRP family mem­
bers may play a cytoarchitectural role during the assembly of 
actin cytoskeletal networks and thereby may affect muscle cell 
differentiation. This idea is supported by our findings that all 
three CRPs are capable of associating with the actin cytoskel- 
eton and that they all interact directly with two cytoskeletal 
proteins, a -actinin and zyxin, both of which have been impli­
cated in the control of actin assembly and organization (21, 25). 
This view is also consistent with the phenotype of mice that 
lack CRP3/MLP; in these mice, the striated muscle cells display 
markedly disorganized myofibrillar arrays and thus fail to 
function properly (26).
Another possibility, which is not mutually exclusive, is that 
the CRP family members may function in the switching of 
master controls that direct a cell’s decision to proliferate or 
differentiate. This idea is consistent with previous findings 
demonstrating that levels of transcripts encoding both CRP1 
and CRP2 decline precipitously in a variety of transformed 
cells (1, 17). It has also been reported that CRP2 expression is 
down-regulated in rat arterial smooth muscle cells in response 
to vascular injuries that trigger cell proliferation (20). In the 
case of CRP3/MLP, it has been clearly demonstrated that pro­
tein expression is low in proliferating myoblasts and increases 
as myogenesis proceeds (19). The fact that all three CRP family 
members are associated with the actin cytoskeleton, perhaps 
via interactions with the cytoskeletal proteins a -actinin and 
zyxin, suggests that the cytoskeleton represents one execution 
site for CRP activity.
Our results indicate that the different CRP family members 
are likely to perform their cellular functions in distinct loca­
tions within an organism. The observations that CRP3/MLP is 
expressed in organs containing striated muscle and that mice 
lacking CRP3/MLP exhibit severe defects in cardiac and skel­
etal musculature (26) indicate that, in the mouse, CRP3/MLP is 
likely to function predominantly during the development of 
striated muscle tissue. In the chick system, CRP3/MLP may 
also be essential for smooth muscle differentiation in the crop. 
By analogy to what is known about vertebrate CRP3/MLP 
function, one would predict that CRP1 and CRP2 could play 
essential roles during smooth muscle cell differentiation. Based 
on the patterns of expression of CRP1 and CRP2, CRP1 may 
play a significant role in the differentiation of nonvascular 
smooth muscle, such as occurs in the digestive and respiratory 
tracts, whereas CRP2 may function in the differentiation of 
vascular smooth muscle, either alone or in conjunction with 
CRP1. Higher resolution analysis of the expression patterns of 
CRP1 and CRP2 will be necessary to refine further our under­
standing of the roles of these two proteins in development. In 
particular, it will be of interest to learn whether the segrega­
tion of CRPs observed late in chick embryonic development 
(Fig. 5) also occurs at earlier stages.
The significance of isoform diversity has been probed in a 
number of other protein families, including groups of cytoskel- 
etal proteins such as tropomyosins, actins, myosins, and tubu­
lins (46-51). For example, a number of closely related actin 
isoforms that are expressed in temporally and spatially dis­
crete patterns have been characterized (47, 48, 52). Mammals 
exhibit four muscle-specific actin isoforms that display a high 
degree of sequence identity (47, 48, 53). Nevertheless, the sub­
stitution of smooth muscle 7-actin for cardiac a-actin in a 
mouse model results in abnormal cardiac muscle morphology 
and function (53). Studies on the actin family point out that 
even a high degree of sequence identity is not sufficient to 
ensure functional conservation. Although we have not yet de­
tected any differences among the CRP family members in 
terms of binding-partner specificity or subcellular distribution, 
we cannot rule out the possibility that within a specific cellular 
context, these proteins perform unique functions. Experiments 
designed to test whether CRP isoforms can substitute for each 
other within a living organism will provide the ultimate test of 
their functional relationships.
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